The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Sprodiamide     2-[bis[2-(carboxylatomethyl...

Synonyms: DyDTPA-BMA, MOLI001031, S-043, AC1L2HBD, AR-1I7083, ...
This record was replaced with 60755.
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of 2-[bis[2-(carboxymethyl-(methylcarbamoylmethyl)amino)ethyl]amino]acetic acid

 

High impact information on 2-[bis[2-(carboxymethyl-(methylcarbamoylmethyl)amino)ethyl]amino]acetic acid

 

Chemical compound and disease context of 2-[bis[2-(carboxymethyl-(methylcarbamoylmethyl)amino)ethyl]amino]acetic acid

  • PURPOSE: To use (a) dysprosium-based contrast agent (sprodiamide) to confirm the site of myocardial injection and (b) T1-enhancing magnetic resonance (MR) contrast media to mark the myocardial target and T2*-enhancing contrast media to demonstrate injection sites in the margins or core of infarction on delayed contrast-enhanced images [1].
 

Analytical, diagnostic and therapeutic context of 2-[bis[2-(carboxymethyl-(methylcarbamoylmethyl)amino)ethyl]amino]acetic acid

  • Administration of 0.10-1.0 mmol/kg DyDTPA-BMA shortened the time for detection of perfusion deficits (residual hyperintensity) in 22 of 36 (61%) treated cats, often to within 30 min after arterial occlusion [2].
  • The evolution of a photochemically induced cortical infarct was monitored using T2-, postcontrast (GdDOTA) T1-, and postcontrast (DyDTPA-BMA) T2*-weighted NMR imaging techniques [9].

References

  1. MR guidance of targeted injections into border and core of scarred myocardium in pigs. Saeed, M., Martin, A.J., Lee, R.J., Weber, O., Revel, D., Saloner, D., Higgins, C.B. Radiology. (2006) [Pubmed]
  2. Cerebrovascular transit characteristics of DyDTPA-BMA and GdDTPA-BMA on normal and ischemic cat brain. Kucharczyk, J., Asgari, H., Mintorovitch, J., Vexler, Z., Rocklage, S., Watson, A., Moseley, M. AJNR. American journal of neuroradiology. (1993) [Pubmed]
  3. Magnetic susceptibility of Dy-DTPA-BMA to reperfused myocardial infarction in an excised dog heart model: evidence of viable myocardium. Zhao, S., Revel, D., Arteaga, C., Canet, E., Liu, S., Hadour, G., Forrat, R., Oksendal, A. Chin. Med. J. (2000) [Pubmed]
  4. Contrast-to-noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection. Lev, M.H., Kulke, S.F., Sorensen, A.G., Boxerman, J.L., Brady, T.J., Rosen, B.R., Buchbinder, B.R., Weisskoff, R.M. Journal of magnetic resonance imaging : JMRI. (1997) [Pubmed]
  5. Low molecular weight lanthanide contrast agents: in vitro studies of mechanisms of action. Fossheim, S., Saebø, K.B., Fahlvik, A.K., Rongved, P., Klaveness, J. Journal of magnetic resonance imaging : JMRI. (1997) [Pubmed]
  6. Quantification of the extent of area at risk with fast contrast-enhanced magnetic resonance imaging in experimental coronary artery stenosis. Saeed, M., Wendland, M.F., Szolar, D., Sakuma, H., Geschwind, J.F., Globits, S., Derugin, N., Higgins, C.B. Am. Heart J. (1996) [Pubmed]
  7. First-pass contrast-enhanced inversion recovery and driven equilibrium fast GRE imaging studies: detection of acute myocardial ischemia. Saeed, M., Wendland, M.F., Lauerma, K., Sakuma, H., Chew, W., Derugin, N., Higgins, C.B. Journal of magnetic resonance imaging : JMRI. (1995) [Pubmed]
  8. Detection of reperfused ischemia of the rat intestine: value of magnetic resonance imaging with small-molecular-weight dysprosium and gadolinium chelates. Van Beers, B.E., Goudemant, J.F., Oksendal, A., Jamart, J., Delos, M., Thiran, J.P., Demeure, R., Pringot, J., Maldague, B. Academic radiology. (1997) [Pubmed]
  9. Complementary use of T2-weighted and postcontrast T1- and T2*-weighted imaging to distinguish sites of reversible and irreversible brain damage in focal ischemic lesions in the rat brain. Lanens, D., Spanoghe, M., Van Audekerke, J., Oksendal, A., Van der Linden, A., Dommisse, R. Magnetic resonance imaging. (1995) [Pubmed]
 
WikiGenes - Universities